Phytochemical evaluation of Zanthoxylum monophyllum has led to the isolation of the alkaloid 4-methoxy-N-methyl-2quinolone (1) with a significant activity against methicillin-resistant Staphylococcus aureus (MRSA), with an IC 50 value of 1.5 μg /mL. Xenobiotic biotransformation of 1 has been conducted with the general goal of increasing the bioactivity of the compound and contributing new leads for further pharmacological research. Twenty-nine microorganisms were used for screening and two (Aspergillus flavus and Cunninghamella echinulata var.echinulata) were able to transform compound 1 to 4methoxy-2-quinolone (2). Structural identification of the compounds was based on NMR, IR, and MS data.
The alkaloid 4-methoxy-N-methyl-2-quinolone (1) was isolated during our phytochemical studies of Zanthoxylum monophyllum P.Wilson. The genus Zanthoxylum is well known to be a source of alkaloids, coumarins, and lignans [1a-1c] . Z. monophyllum has been used in folkloric medicine to treat ocular infections and toothache. Studies have demonstrated that compound 1 is a weak antimutagenic agent, and promoter of cellular differentiation in the HL-60 cell differentiation assay [1d,1e] . In our case, compound 1 showed significant activity against methicillin-resistant Staphylococcus aureus (MRSA), with an IC 50 of 1.5 µg /mL vs. 0.06 µg /mL shown by the control, ciprofloxacin, and no toxicity up to 4.76 μg /mL. Other research groups have recognized the structural similarities of 1 to antiviral, antiprotozoal, anti-allergic, and sedative agents [2a-2d] . These relationships offer the possibility of using this lead compound for the production of modified derivatives with potential pharmacological activity.
Xenobiotic microbial biotransformation is an efficient and economical method for providing regio-and stereospecific structural modifications that are otherwise difficult or impossible to achieve using traditional synthetic methods [3a,3b] . The selection of microorganisms was based on previous reports of their ability to transform alkaloids containing secondary or tertiary amines, as well as aromatic rings [3c,3d].
Twenty-nine microorganisms were used to screen for their ability to transform 1. A standard two-stage fermentation procedure was implemented using medium α [4a,4b] with corresponding controls to ensure that new compounds obtained were due to enzymatic biotransformation. Detection of metabolites was performed by TLC and visualized using Dragendorff's spray reagent. Two of the microorganisms (ATCC 9170-Aspergillus flavus and ATCC 9244-Cunninghamella echinulata var. echinulata) were able to transform compound 1 to 4-methoxy-2-quinolone (2). The physical and spectral data for compound 2 were similar to those previously reported [4c] . The scale-up with ATCC 9244 was demonstrated to be more efficient, giving 60% of modified alkaloid versus 20% obtained from ATCC 9170.
Although the microbial N-demethylation of alkaloids has been reported [5a-5c] , this is the first example of the microbial N-demethylation of quinolone alkaloids. Compound 2 showed no significant activity against MRSA. This shows the importance of the N-methyl group for maintaining the antimicrobial activity of the compound against MRSA. Organism and medium: Twenty-nine organisms were used (Supporting Information).). All fermentation experiments were carried out in liquid medium α, consisting of dextrose, 20 g; NaCl, 5 g; Na 2 HPO 4 , 5 g; Peptone S, 5 g; (Acumedia Manufacturers, Inc.) and yeast-extract (Research Organics), 5 g/L of distilled water. The two-stage fermentation procedure was used in all the experiments. The substrate was dissolved in dimethyl sulfoxide (molecular biology grade) at 0.5 mg/mL and 10 mL (equivalent to 5.0 mg of 1) was added to each culture flask. The cultures were incubated for 14 days in a LabLine 3527 tabletop orbital Environ Shaker at 150 rpm and 26-28°C. TLC aluminum sheets 20 x 20 cm Silica gel 60 F254 were developed and dipped in Dragendorff's reagent to analyze the samples. Scale-up biotransformations were performed in 2 1L Erlenmeyer flasks containing 500 mL of medium using the same environmental conditions described previously and the addition of the substrate at a final concentration of 5 mg/100 mL. Exhaustive liquid-liquid extraction was performed with EtOAc and the solvent was evaporated under vacuum at 37°C. Purification of the alkaloid was assured through preparative TLC (Silica gel 20 x 20 cm 250 μm) using CHCl 3 /EtOAc/MeOH (7:2:1) as the mobile phase, followed by multiple recrystallizations from EtOH/EtOAc mixture. Controls for screening and scale-up transformations were run simultaneously with experiments. Antimicrobial assay methods are described in detail elsewhere [5d]. 
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